UCB Pharma hires Avenue for epilepsy work

UCB Pharma has further bolstered PR agency support for its epilepsy treatment Keppra by appointing Avenue HKM to handle a global advocacy programme.

The agency has been hired to boost UCB’s links with opinion-leaders via workshops, lecture tours and think-tank events that it will initially hold in Europe and, later, worldwide.

The appointment, which is for a newly created contract, comes just six weeks after Chandler Chicco Agency was hired to handle Keppra’s global PR (PRWeek, 27 February). CCA will work alongside Avenue HKM, supporting Keppra. The team at Avenue HKM, whose chief executive is Joanna Marchant, reports to Keppra global brand manager Paul De Belder.

Epilepsy is a common condition, affecting around one in every 100 people. Keppra, three years into its global launch, belongs to a newer class of anti-epilepsy drugs.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in